Ten_CD Largest_NNP Investments_NNP 31_CD March_NNP 2003_CD TotalFinaElf_NNP 6.1_CD %_NN of_IN the_DT portfolio_NN saw_VBD its_PRP$ share_NN price_NN fall_NN during_IN the_DT period_NN ,_, TotalFinaElf_NNP Share_NNP price_NN performance_NN although_IN it_PRP outperformed_VBD the_DT market_NN ._.
The_DT company_NN benefited_VBD from_IN the_DT improvement_NN 200_CD in_IN the_DT oil_NN price_NN ,_, which_WDT remained_VBD strong_JJ reflecting_VBG tensions_NNS in_IN the_DT Middle_NNP East_NNP ._.
As_IN such_JJ ,_, 180_CD the_DT holding_NN was_VBD among_IN the_DT stronger_JJR performers_NNS in_IN the_DT portfolio_NN ,_, and_CC we_PRP have_VBP added_VBN 160_CD to_TO our_PRP$ position_NN during_IN the_DT year_NN ._.
TotalFinaElf_NNP has_VBZ the_DT best_JJS production_NN growth_NN profile_NN 140_CD 120_CD among_IN the_DT oil_NN majors_NNS ,_, with_IN 11_CD %_NN production_NN growth_NN achieved_VBD in_IN 2002_CD ._.
Management_NN is_VBZ 100_CD aggressively_RB targeting_VBG improvement_NN in_IN returns_NNS through_IN increased_VBN efficiency_NN and_CC 80_CD 60_CD effective_JJ management_NN of_IN the_DT capital_NN base_NN ._.
The_DT companys_NNS current_JJ share_NN buy_VB back_RB Mar-02_JJ Jun-02_NN Sep-02_NN Dec-02_NN Mar-03_JJ program_NN is_VBZ supported_VBN by_IN the_DT sale_NN of_IN its_PRP$ stake_NN in_IN Sanofi-Synthelabo_NNP and_CC the_DT current_JJ high_JJ oil_NN prices_NNS ._.
Novartis_NNP Share_NNP price_NN performance_NN Novartis_NNP 5.8_CD %_NN of_IN the_DT portfolio_NN has_VBZ strongly_RB outperformed_VBN the_DT stock_NN market_NN over_IN the_DT 80_CD year_NN ,_, despite_IN falling_VBG in_IN absolute_JJ terms_NNS ._.
We_PRP believe_VBP Novartis_NNP is_VBZ one_CD of_IN the_DT best_JJS managed_VBD 70_CD companies_NNS in_IN the_DT pharmaceutical_JJ sector_NN ,_, with_IN a_DT high_JJ return_NN on_IN capital_NN employed_VBN and_CC a_DT 60_CD strong_JJ product_NN portfolio_NN ._.
The_DT outlook_NN for_IN profit_NN growth_NN in_IN 2003_CD is_VBZ more_RBR cautious_JJ ,_, 50_CD however_RB ,_, due_JJ to_TO increasing_VBG investment_NN in_IN marketing_NN and_CC R&D_NNP for_IN pipeline_NN drugs_NNS ,_, which_WDT 40_CD will_MD hit_VB operating_VBG margins_NNS ._.
The_DT company_NN has_VBZ also_RB strengthened_VBN its_PRP$ stake_NN in_IN Roche_NNP to_TO 30_CD 32_CD %_NN ,_, increasing_VBG strategic_JJ uncertainties_NNS ._.
Mar-02_NNP Jun-02_NNP Sep-02_NNP Dec-02_NNP Mar-03_NNP Royal_NNP Dutch_NNP Petroleum_NNP Royal_NNP Dutch_NNP Petroleum_NNP 5.3_CD %_NN of_IN the_DT portfolio_NN performed_VBN in_IN line_NN with_IN the_DT market_NN Share_NN price_NN performance_NN during_IN the_DT year_NN ._.
After_IN a_DT reduction_NN in_IN production_NN targets_NNS and_CC several_JJ significant_JJ 70_CD acquisitions_NNS ,_, returns_NNS have_VBP fallen_VBN below_IN target_NN in_IN 2002_CD ._.
In_IN 2003_CD ,_, the_DT company_NN will_MD focus_VB 60_CD on_IN the_DT integration_NN of_IN the_DT acquired_VBN businesses_NNS and_CC the_DT delivery_NN of_IN synergies_NNS ,_, which_WDT 50_CD should_MD support_VB profitability_NN even_RB in_IN a_DT weaker_JJR oil_NN price_NN environment_NN ._.
We_PRP continue_VBP to_TO 40_CD hold_VBP the_DT company_NN given_VBN its_PRP$ attractive_JJ valuation_NN ,_, illustrated_VBN by_IN a_DT current_JJ dividend_NN yield_NN 30_CD of_IN 4.7_CD %_NN ._.
20_CD Mar-02_NN Jun-02_NN Sep-02_NNP Dec-02_NNP Mar-03_NNP Nestle_NNP 4.4_CD %_NN of_IN the_DT portfolio_NN has_VBZ outperformed_VBN the_DT market_NN again_RB this_DT year_NN ,_, even_RB though_IN the_DT companys_NNS share_VBP price_NN fell_VBD in_IN absolute_JJ terms_NNS ._.
We_PRP believe_VBP that_IN the_DT current_JJ Nestle_NNP valuation_NN is_VBZ attractive_JJ and_CC does_VBZ not_RB reflect_VB the_DT quality_NN and_CC stability_NN of_IN the_DT companys_NNS Share_NN price_NN performance_NN earnings_NNS stream_NN from_IN leading_VBG brands_NNS including_VBG Nescafe_NNP ,_, Perrier_NNP and_CC Friskies_NNP ._.
We_PRP have_VBP 450_CD increased_VBD our_PRP$ exposure_NN to_TO the_DT company_NN as_IN we_PRP believe_VBP the_DT markets_NNS concerns_NNS about_IN the_DT 400_CD 350_CD US_NNP Dollar_NNP and_CC the_DT impact_NN of_IN rising_VBG commodity_NN prices_NNS on_IN margins_NNS are_VBP overdone_VBN ._.
The_DT 300_CD company_NN is_VBZ now_RB implementing_VBG several_JJ cost_NN reduction_NN and_CC efficiency_NN programs_NNS that_WDT 250_CD are_VBP expected_VBN to_TO drive_VB a_DT significant_JJ improvement_NN in_IN margins_NNS in_IN the_DT medium_JJ term_NN ._.
200_CD 150_CD Mar-02_NN Jun-02_NN Sep-02_NNP Dec-02_NNP Mar-03_NNP Roche_NNP 3.6_CD %_NN of_IN the_DT portfolio_NN saw_VBD its_PRP$ share_NN price_NN outperform_VBP the_DT market_NN after_IN the_DT recent_JJ implementation_NN of_IN restructuring_NN plans_NNS by_IN the_DT new_JJ management_NN team_NN ._.
Now_RB a_DT Roche_NNP third_JJ owned_VBN by_IN Novartis_NNP ,_, the_DT company_NN is_VBZ under_IN pressure_NN to_TO deliver_VB higher_JJR margins_NNS and_CC Share_NN price_NN performance_NN stronger_JJR sales_NNS growth_NN going_VBG forward_RB ._.
We_PRP are_VBP confident_JJ that_IN profit_NN growth_NN will_MD be_VB 140_CD robust_JJ thanks_NNS to_TO the_DT growth_NN of_IN the_DT companys_NNS oncology_JJ franchise_NN and_CC the_DT integration_NN 120_CD benefits_NNS from_IN Chugai_NNP ,_, a_DT Japanese_JJ firm_NN acquired_VBN in_IN 2002_CD ._.
New_JJ products_NNS such_JJ as_IN 100_CD Pegasys_NNPS for_IN Hepatitis_NNP C_NNP and_CC Fuzeon_NNP for_IN AIDS_NNP look_VBP promising_JJ ._.
We_PRP believe_VBP that_IN the_DT 80_CD shares_NNS remain_VBP attractively_RB valued_VBN and_CC will_MD rise_VB on_IN news_NN of_IN improving_VBG momentum_NN in_IN 60_CD sales_NNS ._.
40_CD Mar-02_NN Jun-02_NN Sep-02_NNP Dec-02_NNP Mar-03_NNP Local_JJ currency_NN year_NN ended_VBD 31_CD March_NNP 2003_CD ._.
Merrill_NNP Lynch_NNP European_NNP Investment_NNP Trust_NNP plc_NN 9_CD Ten_CD Largest_NNP Investments_NNP continued_VBD 31_CD March_NNP 2003_CD Nokia_NNP Nokia_NNP 3.6_CD %_NN of_IN the_DT portfolio_NN has_VBZ delivered_VBN a_DT disappointing_JJ share_NN price_NN performance_NN Share_NN price_NN performance_NN despite_IN retaining_VBG its_PRP$ dominant_JJ competitive_JJ position_NN in_IN key_JJ markets_NNS ._.
We_PRP believe_VBP recent_JJ 30_CD concerns_NNS on_IN increased_VBN competition_NN in_IN the_DT handset_NN market_NN from_IN Asian_JJ suppliers_NNS are_VBP 25_CD overdone_VBN and_CC that_IN the_DT current_JJ valuation_NN is_VBZ attractive_JJ given_VBN the_DT potential_NN for_IN new_JJ 20_CD products_NNS to_TO boost_VB sales_NNS in_IN 2003_CD ._.
The_DT company_NN is_VBZ also_RB generating_VBG substantial_JJ cashflows_NNS 15_CD which_WDT we_PRP expect_VBP to_TO be_VB used_VBN to_TO buy_VB back_RP its_PRP$ shares_NNS in_IN the_DT future_NN ._.
We_PRP have_VBP added_VBN to_TO the_DT 10_CD holding_NN recently_RB ._.
5_CD 0_CD Mar-02_NNP Jun-02_NNP Sep-02_NNP Dec-02_NNP Mar-03_NNP BNP_NNP Paribas_NNP 3.5_CD %_NN of_IN the_DT portfolio_NN saw_VBD its_PRP$ share_NN price_NN weaken_VBP during_IN the_DT year_NN as_IN concerns_NNS grew_VBD about_IN the_DT potential_JJ impact_NN of_IN rising_VBG bad_JJ debts_NNS and_CC weaker_JJR revenues_NNS on_IN BNP_NNP Paribas_NNP profits_NNS ._.
We_PRP added_VBD to_TO the_DT holding_NN during_IN the_DT period_NN to_TO December_NNP 2002_CD to_TO benefit_VB from_IN Share_NN price_NN performance_NN share_NN price_NN weakness_NN following_VBG the_DT companys_NNS acquisition_NN of_IN a_DT stake_NN in_IN Credit_NNP Lyonnais_NNP ,_, 70_CD its_PRP$ domestic_JJ rival_NN ._.
We_PRP believe_VBP that_IN the_DT risk_NN of_IN dilution_NN from_IN participation_NN in_IN the_DT 60_CD consolidation_NN of_IN the_DT French_JJ banking_NN industry_NN is_VBZ fully_RB discounted_VBN at_IN the_DT current_JJ 50_CD valuation_NN ._.
Management_NN are_VBP committed_VBN to_TO generating_VBG good_JJ returns_NNS for_IN shareholders_NNS 40_CD and_CC the_DT franchise_NN is_VBZ strong_JJ ._.
30_CD 20_CD Mar-02_NN Jun-02_NN Sep-02_NNP Dec-02_NNP Mar-03_NNP UniCredito_NNP Italiano_NNP 2.8_CD %_NN of_IN the_DT portfolio_NN saw_VBD its_PRP$ share_NN price_NN significantly_RB outperform_VBP the_DT market_NN and_CC its_PRP$ peer_VB group_NN ._.
We_PRP believe_VBP it_PRP is_VBZ well_RB managed_VBN ,_, benefits_NNS UniCredito_NNP Italiano_NNP from_IN its_PRP$ location_NN in_IN the_DT more_RBR prosperous_JJ northern_JJ part_NN of_IN Italy_NNP ,_, and_CC is_VBZ leading_VBG the_DT Share_NN price_NN performance_NN consolidation_NN of_IN the_DT Italian_JJ banking_NN sector_NN ._.
The_DT acquisition_NN of_IN a_DT leading_VBG Polish_JJ bank_NN has_VBZ 6_CD proven_VBN to_TO be_VB successful_JJ ,_, gaining_VBG the_DT company_NN a_DT key_JJ position_NN in_IN part_NN of_IN the_DT emerging_VBG 5_CD eastern_JJ European_JJ market_NN ._.
After_IN the_DT failed_VBN attempt_NN to_TO acquire_VB Commerzbank_NNP ,_, it_PRP is_VBZ 4_CD concentrating_VBG on_IN the_DT reorganisation_NN of_IN its_PRP$ Italian_JJ operations_NNS ,_, as_IN evidenced_VBN by_IN the_DT 3_CD acquisition_NN of_IN the_DT minority_NN interests_NNS in_IN Rolo_NNP Banca_NNP ._.
There_EX are_VBP early_RB signs_NNS that_IN this_DT 2_CD project_NN will_MD provide_VB significant_JJ synergies_NNS ._.
1_CD Mar-02_NNP Jun-02_NNP Sep-02_NNP Dec-02_NNP Mar-03_NNP Unilever_NNP 2.8_CD %_NN of_IN the_DT portfolio_NN delivered_VBD a_DT relatively_RB stable_JJ share_NN price_NN performance_NN during_IN the_DT period_NN ,_, despite_IN the_DT volatile_JJ market_NN environment_NN ._.
The_DT companys_NNS focus_VB on_IN Unilever_NNP Share_NNP price_NN performance_NN developing_VBG its_PRP$ top_JJ brands_NNS with_IN either_DT global_JJ coverage_NN or_CC local_JJ niches_NNS ,_, together_RB with_IN efficiency_NN and_CC cost_NN reduction_NN programs_NNS ,_, led_VBD to_TO strong_JJ profit_NN growth_NN in_IN 2002_CD ._.
The_DT 80_CD 70_CD management_NN has_VBZ aggressive_JJ margin_NN targets_NNS and_CC is_VBZ confident_JJ that_IN the_DT momentum_NN will_MD 60_CD continue_VBP ._.
We_PRP have_VBP been_VBN adding_VBG to_TO the_DT holding_NN ._.
50_CD 40_CD E._NNP On_IN 2.5_CD %_NN of_IN the_DT portfolio_NN posted_VBD a_DT resilient_JJ share_NN price_NN performance_NN during_IN the_DT 30_CD period_NN due_JJ to_TO a_DT successful_JJ series_NN of_IN disposals_NNS of_IN non-core_JJ businesses_NNS at_IN decent_JJ prices_NNS ,_, 20_CD Mar-02_NN Jun-02_NN Sep-02_NNP Dec-02_NNP Mar-03_NNP the_DT impact_NN of_IN rising_VBG energy_NN prices_NNS in_IN Germany_NNP and_CC further_JJ share_NN buy_VB backs_NNS ._.
With_IN the_DT approval_NN for_IN its_PRP$ takeovers_NNS of_IN Powergen_NNP and_CC Ruhrgas_NNP ,_, management_NN have_VBP refocused_VBN on_IN E._NNP On_IN the_DT companys_NNS core_NN operations_NNS as_IN a_DT global_JJ energy_NN utility_NN business_NN ._.
The_DT balance_NN sheet_NN is_VBZ Share_NN price_NN performance_NN strong_JJ and_CC market_NN fears_NNS regarding_VBG management_NN succession_NN have_VBP been_VBN resolved_VBN ._.
We_PRP 70_CD believe_VBP the_DT company_NN remains_VBZ attractively_RB valued_VBN ._.
